Table 3.

Number of mast cell colonies that developed after plating bone marrow, spleen, and peripheral blood mononuclear cells of WBB6F1-+/+ or WBB6F1-tg/tg mice in the presence of IL-3 alone or of both IL-3 and KitL



No. of colonies in each culture condition
IL-3*
IL-3 + KitL
Cells
WBB6F1-+/+
WBB6F1-tg/tg
WBB6F1-+/+
WBB6F1-tg/tg
Bone marrow   2.8 ± 0.5   2.7 ± 0.5   8.0 ± 0.8   3.0 ± 0.5 
Spleen   17.8 ± 5.4   11.5 ± 3.1   29.8 ± 6.1   10.0 ± 4.8 
Blood   1.3 ± 0.5   0.8 ± 0.3   5.8 ± 1.4   1.0 ± 0.7 
BMMC
 
4.3 ± 1.4
 
3.2 ± 0.9
 
16.2 ± 3.4
 
5.5 ± 0.8
 


No. of colonies in each culture condition
IL-3*
IL-3 + KitL
Cells
WBB6F1-+/+
WBB6F1-tg/tg
WBB6F1-+/+
WBB6F1-tg/tg
Bone marrow   2.8 ± 0.5   2.7 ± 0.5   8.0 ± 0.8   3.0 ± 0.5 
Spleen   17.8 ± 5.4   11.5 ± 3.1   29.8 ± 6.1   10.0 ± 4.8 
Blood   1.3 ± 0.5   0.8 ± 0.3   5.8 ± 1.4   1.0 ± 0.7 
BMMC
 
4.3 ± 1.4
 
3.2 ± 0.9
 
16.2 ± 3.4
 
5.5 ± 0.8
 

Values represent the mean ± SE of 6 mice (bone marrow, spleen, and blood) or of 3 cultures (BMMC) and are given as the number per 4 × 104 bone marrow cells, 2 × 105 spleen and peripheral blood mononuclear cells, and 5 × 102 CMCs.

*

Culture medium containing 10 ng/mL IL-3.

Culture medium containing 10 ng/mL IL-3 and 50 ng/mL KitL.

P < .01 by t test when compared with the value of WBB6F1-+/+ mice.

or Create an Account

Close Modal
Close Modal